The Weekly AI Briefing

AI intelligence for
health planhospitalstartupemployerhealth leaders.

What's moving. What's proven. What matters.

3 Signals
—
2 Studies
—
1 Insight

Free • Weekly • 5 min read

The Format

What you get every Friday

3

Market Signals

The AI news that matters for health plans this week. Vendor moves, regulatory shifts, competitor deployments—filtered for relevance.

Examples

CMS rules M&A activity New pilots HHS changes Key partnerships
2

Research Studies

Fresh research on AI in healthcare—clinical trials, health services research, real-world evidence. Summarized with implications for payers.

Sources

JAMA NEJM Health Affairs Nature Medicine npj Digital Medicine
1

Key Insight

The single most important takeaway from this week. Actionable, opinionated, and designed to spark your Monday strategy conversations.

Examples

Strategic moves Vendor bets ROI frameworks Build vs. buy AI leadership

Newsletter Archive

Past Issues

Curated Library

What leaders are reading

N J.P. Morgan / MobiHealthNews
Key Insight

AI is no longer a health tech category. It is health tech.

J.P. Morgan's 2025 health tech report: 75% of all health tech funding now goes to AI-focused companies—up from ~50% two years ago. The shift isn't just about new AI startups. Every category—benefits administration, clinical trials, care delivery—is being reframed as an AI problem.

Takeaway
Your next vendor pitch won't ask if they use AI. They all do. The question is whether their AI claims are backed by outcomes data—or just marketing.
Dec 9, 2025 Read report
N HHS.gov
Signal

HHS unveils "OneHHS" unified AI strategy

First unified AI infrastructure across CMS, FDA, CDC, and NIH. Target metrics: hospital readmissions, sepsis mortality, maternal health outcomes.

So what?
Four agencies, one AI agenda. And ChatGPT is now available to everybody at HHS.
Dec 9, 2025 Read strategy
N FDA
Signal

FDA deploys agentic AI for drug reviews

First federal agency using autonomous AI agents. Internal tool "Elsa" now used by 70% of staff for document review and submission analysis.

So what?
If FDA trusts agentic AI, payers will likely face similar expectations.
Dec 9, 2025 Read announcement
N CMS Innovation
Signal

CMS WISeR pilot launches with AI prior auth

Six-state Original Medicare pilot (AZ, NJ, OH, OK, TX, WA) testing AI-powered prior auth for "waste-prone" services. Private vendors doing reviews. Runs through 2031.

So what?
This becomes the benchmark every MA plan is measured against.
Dec 9, 2025 Read details
R JAMA Network
Study

JAMA Summit: "Medicine is flying blind on AI"

Consensus from 60+ leaders in medicine, law, and policy. Conclusion: AI adoption has outpaced evidence. Key recommendations include expanded FDA oversight and outcome-based evaluation standards.

Why it matters
"Outcome-based evaluation" could become regulatory language.
Dec 9, 2025 Read report
R AMA
Study

60% of physicians say AI systematically denies care

AMA survey of 1,000 physicians. 93% report prior auth delays care. One system reported AI denial rates 16x higher than human reviewers.

Why it matters
Perception often drives policy. CA and NY already drafting transparency bills citing this.
Dec 9, 2025 Read survey

Archive grows with each issue. Subscribe to never miss a signal.

Get the briefing

Built for health plan executives, by someone who gets it

10+

Years in healthcare strategy and health tech

50+

Payers advised on AI, care management, and member engagement

1

Mission: cut through the noise so you don't have to

Join the briefing

3 Signals
—
2 Studies
—
1 Insight
Read Source →